RAVULIZUMAB-CWVZ | B761108 | ALEXION PHARM
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Dec. 21, 2030 | Active | Computed |
| 7-Year Orphan | Jun. 7, 2028 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12404320(method of use) · relevance 90/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
39 AI-discovered patents, sorted by relevance.
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2019-11-12 | Terminated 2022-05-04 | — | |
| D. Del. | 2018-11-15 | Terminated 2022-03-17 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.